Goldman Sachs made a significant adjustment to its stance on Regenxbio Inc . (NASDAQ:RGNX), downgrading the stock from "Buy" to "Neutral" and reducing the price target dramatically to $14.00 from the ...
Goldman Sachs downgraded Dynavax Technologies Corporation (NASDAQ:DVAX) stock from Neutral to Sell, adjusting the price target downward to $12.00 from the previous $15.00. According to InvestingPro ...
Big data analytics company Palantir Technologies (PLTR) saw its price target double to $80 from $41 by Goldman Sachs analyst ...
To build the Argus U.S. ESG Model Portfolio, we applied financial concepts such as industry diversification, income generation, risk reduction, and growth at a reasonable price to our various lists.
7hon MSN
Following Q3FY25 results, Eicher Motors’ stock dropped nearly 7% as Goldman Sachs lowered its target price. The company ...
While the stock remains pricey relative to historical ... now totaling $36.5 billion. Price Action: GS shares are trading higher by 0.88% at $611.28 at the last check Thursday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback